Source - LSE Regulatory
RNS Number : 9504H
Ovoca Bio PLC
11 October 2024
 

Ovoca Bio plc

 

("Ovoca" or the "Company")

 

 

Holding(s) in Company

 

Dublin, Ireland, October 11, 2024 - Ovoca Bio, a biopharmaceutical company with a focus on women's health, has received notification from Mr. Timothy McCutcheon that, as of 9 October 2014, he holds an interest in 19,506,203 Ordinary Shares of nominal value €0.125 each, which represents approximately 22.05% of the Company's issued share capital. This percentage shareholding is based on the latest shares in issue figure of 88,458,806 ordinary shares of nominal value €0.125 each following the Company's recent sale of ordinary shares from treasury, as announced on 9 October 2024.

End

 

For further information:


Ovoca Bio plc

Tim McCutcheon (Chief Executive Officer)

Tel +353 1 661 9819

info@ovocabio.com

 

Davy (Nominated Adviser, Euronext Growth Listing Sponsor and Broker)

Ivan Murphy / Daragh O'Reilly

Tel: +353 1 679 6363

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFLFLRIELLLIS
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJ Bell logo

Related Charts

Ovoca Bio PLC (OVB)

-0.02p (-1.11%)
delayed 14:59PM